[ Price : $8.95]
Six stakeholders comment on an FDA draft guidance on the CDRH Voluntary Improvement Program for medical device manufacturers.[ Price : $8.95]
Intercept Pharmaceuticals says it will resubmit an NDA to FDA for its obeticholic acid to treat patients with liver fibrosis due t...[ Price : $8.95]
Federal Register notice: FDA seeks consumer organizations interested in participating in the selection of voting and nonvoting con...[ Price : $8.95]
FDA says clinical trial results show an increased risk of death and serious side effects associated with Secura Bios cancer drug C...[ Price : $8.95]
FDA clears a LiveMetric 510(k) for its LiveOne, a wrist-worn nano-sensor technology for monitoring blood pressure every 10 seconds...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Rhythm Pharmaceuticals Imci...[ Price : $8.95]
FDA issues AFT Pharmaceuticals a complete response letter on its NDA for Maxigesic IV, a combination of 1,000 mg paracetamol and 3...[ Price : $8.95]
Royal Philips teams up with Biodesix to add the results of Biodesixs Nodify Lung blood-based lung nodule risk assessment testing i...